Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 12.15 | N/A |
| PEG Ratio (TTM) | 2.36 | N/A |
| P/S Ratio (TTM) | 3.02 | N/A |
| P/B Ratio (TTM) | 1.13 | N/A |
| P/FCF Ratio (TTM) | 9.09 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.25 | N/A |
| Price to 5YR AVG FCF Ratio | 9.55 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.11% | N/A |
| ROE (TTM) | 9.89% | N/A |
| Net Profit Margin (TTM) | 24.88% | N/A |
| ROIC 5YR AVG | 11.35% | N/A |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 18.61% | 329.98% | 195.97% |
| Revenue | 7.15% | 4.61% | 3.19% |
| Net Income | 18.19% | 337.57% | 200.15% |
| Cash Flow | 7.26% | 14.72% | 9.35% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 11.41 | N/A |
| Quick Ratio (TTM) | 11.41 | N/A |
| D/E Ratio (TTM) | 0.18 | N/A |
| Interest Coverage (TTM) | 1.55 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 0.52 | N/A |
| LTL to 5YR AVG FCF | 0.73 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.18% | N/A |